Sino Biopharmaceutical Limited (“Sino Biopharm” or the “Company”, together with its subsidiaries, the “Group”) (HKEX:1177), a ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular ...

Incyte’s quest for its next big thing ended in disappointment—and a stock tumble—this past week. Unfortunately, the problems ...

Strategic transformation ongoing, positioning the Company as a focused leader in immunology and inflammatory diseasesHighly differentiated, ...

Four development candidates in clinical studies with data anticipated this year, continuing rapid progress of antiviral pipeline –– Interim ...

San Francisco is reassessing its harm reduction efforts by potentially stopping the public distribution of drug-smoking ...

According to studies approximately 15% of cancers are caused by viruses. Read more to know about the viruses that cause ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Adma Biologics (ADMA) witnessed a jump in share price last session on above-average trading volume. The latest trend in ...

Strategic transformation ongoing, positioning the Company as a focused leader in immunology and inflammatory diseasesHighly differentiated, potentially curative immunotherapy for celiac disease (VTP-1 ...

DAP Health was one of 13 of the nation's leading LGBTQ+, HIV, and health organizations that united to condemn the Trump ...